Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 August 2006, Vol. 108, No. 4, pp. 1320-1327.
Prepublished online as a Blood First Edition Paper on May 9, 2006; DOI 10.1182/blood-2005-11-006783.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2005-11-006783v1
108/4/1320    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lobito, A. A.
Right arrow Articles by Siegel, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lobito, A. A.
Right arrow Articles by Siegel, R. M.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)

Adrian A. Lobito, Fiona C. Kimberley, Jagan R. Muppidi, Hirsh Komarow, Adrianna J. Jackson, Keith M. Hull, Daniel L. Kastner, Gavin R. Screaton, and Richard M. Siegel

From the Immunoregulation Unit, Autoimmunity Branch, and Inflammatory Biology Section, Genetics and Genomics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD; Department of Pharmacology, Toxicology, & Therapeutics, University of Kansas Medical Center, Kansas City; and Hammersmith Hospital, Imperial College London, United Kingdom.

Tumor necrosis factor (TNF) receptor–associated periodic syndrome (TRAPS) is an autosomal dominant systemic autoinflammatory disease associated with heterozygous mutations in TNF receptor 1 (TNFR1). Here we examined the structural and functional alterations caused by 9 distinct TRAPS-associated TNFR1 mutations in transfected cells and a mouse "knock-in" model of TRAPS. We found that these TNFR1 mutants did not generate soluble versions of the receptor, either through membrane cleavage or in exosomes. Mutant receptors did not bind TNF and failed to function as dominant-negative inhibitors of TNFR1-induced apoptosis. Instead, TRAPS mutant TNFR1 formed abnormal disulfide-linked oligomers that failed to interact with wild-type TNFR1 molecules through the preligand assembly domain (PLAD) that normally governs receptor self-association. TRAPS mutant TNFR1 molecules were retained intracellularly and colocalized with endoplasmic reticulum (ER) markers. The capacity of mutant receptors to spontaneously induce both apoptosis and nuclear factor {kappa}B (NF-{kappa}B) activity was reduced. In contrast, the R92Q variant of TNFR1 behaved like the wild-type receptor in all of these assays. The inflammatory phenotype of TRAPS may be due to consequences of mutant TNFR1 protein misfolding and ER retention.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
T. Kumpfel, L-A Hoffmann, H. Pellkofer, W. Pollmann, W. Feneberg, R. Hohlfeld, and P. Lohse
Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases
Neurology, November 25, 2008; 71(22): 1812 - 1820.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S M Churchman, L D Church, S Savic, L R Coulthard, B Hayward, B Nedjai, M D Turner, R J Mathews, E Baguley, G A Hitman, et al.
A novel TNFRSF1A splice mutation associated with increased nuclear factor {kappa}appaB (NF-{kappa}B) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS)
Ann Rheum Dis, November 1, 2008; 67(11): 1589 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S Stojanov, C Dejaco, P Lohse, K Huss, C Duftner, B H Belohradsky, M Herold, and M Schirmer
Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment
Ann Rheum Dis, September 1, 2008; 67(9): 1292 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
Q. Yao and D. E. Furst
Autoinflammatory diseases: an update of clinical and genetic aspects
Rheumatology, July 1, 2008; 47(7): 946 - 951.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
S. Farasat, I. Aksentijevich, and J. R. Toro
Autoinflammatory Diseases: Clinical and Genetic Advances
Arch Dermatol, March 1, 2008; 144(3): 392 - 402.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A.-S. Dhaunchak and K.-A. Nave
A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus Merzbacher disease
PNAS, November 6, 2007; 104(45): 17813 - 17818.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Simon and J. W. M. van der Meer
Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R86 - R98.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020